Wobble Genomics: Revolutionizing RNA Sequencing Technology and Beyond
Impressed Richard Kuo🚀 Wobble Genomics closed £8,500,000 in an outstanding growth funding round.
Wobble Genomics, a company based in Edinburgh, Scotland, UK, is revolutionizing RNA sequencing with its novel approach. Recently, the company raised £8.5M in funding, bringing the total amount to $10.5M. The funding round was led by Mercia Ventures and BGF, with support from IQ Capital, EOS Advisors, and Old College Capital - the university’s venture fund. The goal of the funding is to accelerate the commercialization of Wobble Genomics' technology.
CEO Richard Kuo is leading the team at Wobble Genomics, a spin-out from the University of Edinburgh.
The company specializes in optimizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers. The innovative technology developed by Wobble Genomics has vast applications, spanning across drug development, research, agriculture, and ecology. With a current team of 10 employees, the company is planning to expand and double in size over the next two years.
Richard Kuo expressed his excitement about the latest funding round and the future prospects of genetic sequencing. He highlighted the shift from short-read to long-read sequencing, with long-read RNA sequencing presenting significant opportunities in biotechnology. The support from prominent life science investors in the UK underscores the potential of Wobble Genomics' solution. The funding will enable the company to advance its mission of exploring the world of RNA and unlocking new applications in the field of biotechnology.
They've invested in Wobble Genomics
Get to know these Biotech investors
Click here for a full list of 6,528+ startup investors in the UK